How much funding has Zafrens raised?

Zafrens has raised $31.0M in total funding, most recently a Extension Round.

Who are Zafrens's investors?

Zafrens's investors include Prime Movers Lab, IMEC XPand, KOFA Healthcare, Global Brain, BlueYard Capital.

Where is Zafrens headquartered?

Zafrens is headquartered in San Diego, California, United States.

What industry is Zafrens in?

Zafrens operates in Artificial Intelligence, Biotech, Healthcare.

Zafrens

Redefining drug discovery for the AI era

San Diego, United States · $31.0M raised

Artificial Intelligence

Biotech

Healthcare

Headquarters: San Diego, California
Employees: 11–50
Business Model: B2B
Website: zafrens.com

Total Funding: $31.0M
Last Round: $8.0M Extension RoundFeb 2025
Rounds: 2

About

Zafrens is a therapeutics and drug discovery company pioneering an ultra-high-throughput platform called Z-Screen that isolates, cultures, images, and sequences millions of cells per day. By pairing molecular and functional data at unprecedented scale and resolution, Zafrens enables pharmaceutical and biotech partners to compress drug discovery timelines and unlock therapeutic opportunities across all modalities including immunotherapy, small molecules, and biologics. The company was founded by Swamy Vijayan and Yi Zhang and is headquartered in San Diego, California.

Summary

Zafrens is an Artificial Intelligence company based in San Diego, United States. It has raised $31.0M in total across 2 rounds, most recently a $8.0M Extension Round round in Feb 2025. Investors include Prime Movers Lab, IMEC XPand and KOFA Healthcare.